Related Experiment Video
Updated: Apr 21, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis
Jay-Hyun Jo1, Tae-Moon Chung2, Hyewon Youn3
1Department of Life Sciences, Pohang University of Science and Technology, Life Science Building 208, POSTECH, Nam-Gu, Pohang, Gyungbuk 790-784, Korea.
Abstract:
The parafibromin/hCdc73 is a component of the PAFc, which controls RNA polymerase II-mediated general transcription. In parathyroid carcinoma and familial autosomal dominant hyperparathyroidism-jaw tumour (HPT-JT), hCdc73 mutations are heavily implicated, yet the underlying mechanism of its carcinogenic action is poorly understood. Here we demonstrate that hCdc73 specifically controls messenger RNA stability of p53 and p53-mediated apoptosis. hCdc73 is associated with mature p53 mRNA in the cytoplasm and facilitates its degradation. Cytoplasmic hCdc73 physically interacts with eEF1Bγ and hSki8, and this interaction is required to bind and destabilize p53 mRNA. Furthermore, enhanced association of p53 mRNA with a cancer-driven hCdc73(K34Q) mutant was also observed. As a result, reduced p53 expression as well as enhanced cell proliferation was acquired in the hCdc73 (K34Q)-overexpressed cells. Altogether, our findings indicate that hCdc73 directly targets p53 mRNA to repress p53 expression, and aberrant regulation of this interaction may lead to tumour progression.
Insights
The parafibromin/hCdc73 protein regulates p53 mRNA stability, controlling apoptosis and cell proliferation. Mutations in hCdc73 can lead to tumor progression by disrupting this crucial mechanism.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The parafibromin/hCdc73 protein is part of the PAFc complex, essential for RNA polymerase II transcription.
- Mutations in hCdc73 are linked to parathyroid carcinoma and HPT-JT syndrome, but the mechanism of its oncogenic action is unclear.
Purpose of the Study:
- To elucidate the role of hCdc73 in regulating p53 mRNA stability and its implications in cancer.
- To investigate the molecular interactions of hCdc73 with p53 mRNA and associated proteins.
Main Methods:
- Investigated hCdc73's effect on p53 mRNA stability and p53-mediated apoptosis.
- Performed co-immunoprecipitation to identify interacting proteins of hCdc73 in the cytoplasm.
- Analyzed the impact of a cancer-associated hCdc73 mutant (K34Q) on p53 mRNA and cell proliferation.
Main Results:
- hCdc73 directly binds to mature p53 mRNA in the cytoplasm, promoting its degradation.
- hCdc73 interacts with eEF1Bγ and hSki8 to destabilize p53 mRNA.
- Overexpression of the hCdc73(K34Q) mutant enhances p53 mRNA association, reduces p53 expression, and increases cell proliferation.
Conclusions:
- hCdc73 acts as a direct regulator of p53 mRNA stability, thereby controlling p53 expression and apoptosis.
- Aberrant regulation of the hCdc73-p53 mRNA interaction contributes to tumor progression in parathyroid diseases.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
The Intrinsic Apoptotic Pathway

